Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Dual Therapy”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01382147
What this trial is testing

Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Prof. Dr. Wolfgang Hiddemann 396
Large-scale testing (Phase 3)Study completedNCT00452439
What this trial is testing

Actonel for the Prevention of Bone Loss

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 72
Early research (Phase 1)Ended earlyNCT01145014
What this trial is testing

To Investigate Safety, Tolerability, and Pharmacokinetics of Treatment With BI 660848 Rising Single Doses (From 2 mg to 600 mg) Administered as Oral Drinking Solution (Powder in Bottle).

Who this might be right for
PainHealthy
Boehringer Ingelheim 72
Large-scale testing (Phase 3)Study completedNCT01604330
What this trial is testing

Baclofen for the Treatment of Alcohol Drinkers

Who this might be right for
Alcoholism
Assistance Publique - Hôpitaux de Paris 323
Post-approval studies (Phase 4)UnknownNCT02769689
What this trial is testing

Methylprednisolone During the Switch Between Natalizumab and Fingolimod

Who this might be right for
Multiple Sclerosis
University Hospital, Clermont-Ferrand 56
Testing effectiveness (Phase 2)Study completedNCT02743949
What this trial is testing

Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)

Who this might be right for
Gastroesophageal Reflux
Takeda 256
Large-scale testing (Phase 3)Ended earlyNCT00144833
What this trial is testing

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Who this might be right for
HIV-1
GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT00202982
What this trial is testing

Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

Who this might be right for
Relapse-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT02502669
What this trial is testing

Finasteride Treatment of Severe Nodulocystic Acne

Who this might be right for
NODULOCYSTIC ACNE
Elorac, Inc. 106
Large-scale testing (Phase 3)Study completedNCT01757275
What this trial is testing

High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer

Who this might be right for
Bleeding Peptic Ulcer
AstraZeneca 239
Not applicableStudy completedNCT01440608
What this trial is testing

Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental Enteropathy

Who this might be right for
Enteropathy
Washington University School of Medicine 225
Post-approval studies (Phase 4)Study completedNCT03405584
What this trial is testing

High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment

Who this might be right for
Helicobacter Pylori Infection
Shanghai Jiao Tong University School of Medicine 160
Large-scale testing (Phase 3)Study completedNCT02075255
What this trial is testing

Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy

Who this might be right for
Asthma
AstraZeneca 220
Very early researchUnknownNCT05100446
What this trial is testing

Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

Who this might be right for
Helicobacter Pylori InfectionGastritisGastric Cancer
Unidade Local de Saúde do Alto Ave, EPE 100
Large-scale testing (Phase 3)Study completedNCT01763905
What this trial is testing

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2

Who this might be right for
Hyperlipidemia
Amgen 307
Testing effectiveness (Phase 2)Study completedNCT00169559
What this trial is testing

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Who this might be right for
Dyslipidaemias
GlaxoSmithKline 250
Post-approval studies (Phase 4)Study completedNCT00241150
What this trial is testing

Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome

Who this might be right for
HypertensionMetabolic Syndrome
Novartis 80
Large-scale testing (Phase 3)Study completedNCT00549939
What this trial is testing

Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction

Who this might be right for
Neurogenic Urinary Bladder
Sanofi 172
Not applicableUnknownNCT05176821
What this trial is testing

Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection

Who this might be right for
H. Pylori Infection
Shanghai Zhongshan Hospital 186
Not applicableStudy completedNCT07121205
What this trial is testing

High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)

Who this might be right for
HELICOBACTER PYLORI INFECTIONS
Liyueyue 1,600
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation